Cambridge, MA-based RNA drug developer Wave Life Sciences (NASDAQ: WVE) has named Keith Regnante its chief financial officer. Regnante was previously the VP of finance at Shire, and had stints at Biogen and Boston Consulting Group before that.
Sponsored · Webinar
A discussion on business drivers, technical considerations, special requirements of cell and gene product manufacturing & digitization strategy
Global OT/IT Quality Services
Sponsored · Whitepaper
What the most successful life sciences fundraising pitch decks all have in common
Brex
Sponsored · Whitepaper
Create well-controlled, biologically relevant test systems and validate them to support FDA approvals
Absorption Systems
